(113 days)
The Vela smooth, Shaper is indicated for the relief of minor muscle aches and pain. Relief of muscle spam Temporary improvement of local blood circulation. Temporary reduction in the appearance of cellulite.
The Vela smooth, Shaper treatment is based on the simultaneous application of heat to the tissue with light energy at a controlled Infrared wavelength, conducted RF energy, and mechanical manipulations of the skin.
This 510(k) summary does not contain the detailed information required to fill out the table and answer all the questions. The provided document is a summary of safety and effectiveness, and the FDA letter approving the device based on substantial equivalence to predicate devices. It does not include information about specific acceptance criteria or a detailed study proving the device meets those criteria in the way a clinical trial report would.
Here's what can be inferred from the document and why other information is missing:
1. Table of Acceptance Criteria and Reported Device Performance:
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Relief of minor muscle aches and pain: | Not explicitly stated in terms of specific metrics or percentages. The device is "indicated for the relief of minor muscle aches and pain." |
| Relief of muscle spasm: | Not explicitly stated in terms of specific metrics or percentages. The device is "indicated for the relief of muscle spasm." |
| Temporary improvement of local blood circulation: | Not explicitly stated in terms of specific metrics or percentages. The device is "indicated for temporary improvement of local blood circulation." |
| Temporary reduction in the appearance of cellulite: | Not explicitly stated in terms of specific metrics or percentages. The device is "indicated for temporary reduction in the appearance of cellulite." |
Explanation for missing data: This document is a 510(k) summary, which focuses on demonstrating substantial equivalence to predicate devices rather than providing detailed clinical trial results with specific performance metrics against pre-defined acceptance criteria. The "Indications for Use" section lists the intended benefits, but doesn't quantify "relief," "improvement," or "reduction" with specific percentages or scales.
2. Sample size used for the test set and the data provenance:
- Sample size: Not available in this document.
- Data provenance: Not available in this document. (Retrospective/prospective, country of origin)
Explanation: A 510(k) summary doesn't typically include details about the sample size or provenance of data from specific clinical trials unless it's a new clinical indication requiring such data. The submission relies on the established safety and effectiveness of the predicate devices.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Number of experts: Not available in this document.
- Qualifications of experts: Not available in this document.
Explanation: This information would be present in a detailed study report, particularly for subjective outcomes like cellulite appearance. It's not part of a 510(k) summary focused on substantial equivalence.
4. Adjudication method for the test set:
- Not available in this document.
Explanation: Adjudication methods (like 2+1 or 3+1) are specified in clinical trial protocols when multiple readers or experts assess outcomes. This is not included in a 510(k) summary.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done, nor would it be relevant for this type of device and submission.
- Effect size: Not applicable.
Explanation: This device is a physical therapeutic device (Vela smooth, Shaper) that uses heat, light, RF energy, and mechanical manipulation. It is not an AI-powered diagnostic or assistive technology for human readers. Therefore, an MRMC study comparing human readers with and without AI assistance is not applicable.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not applicable.
Explanation: As mentioned above, this is a physical therapeutic device, not an algorithm or AI system.
7. The type of ground truth used:
- Not explicitly stated. However, for the indications listed (muscle aches, spasm, blood circulation, cellulite appearance), the "ground truth" would likely involve subjective patient self-reports for pain/spasm, objective measures for blood circulation (e.g., Doppler), and subjective assessments (e.g., visual grading, photographic comparison) perhaps by a clinician or panel for cellulite appearance.
Explanation: Since this is a 510(k) based on substantial equivalence, the "ground truth" for the predicate devices' effectiveness would have been established through clinical observations and measurements over time, rather than a single, easily defined ground truth like pathology for a diagnostic device.
8. The sample size for the training set:
- Not applicable.
Explanation: This device is not an AI/machine learning model, so there is no "training set."
9. How the ground truth for the training set was established:
- Not applicable.
Explanation: This device is not an AI/machine learning model, so there is no "training set" or ground truth establishment for a training set.
{0}------------------------------------------------
K050397
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS SYNERON MEDICAL Ltd. VELASMOOTH, SHAPER
This summary of safety and effectiveness information is being submitted in accordance with the requircments of the SMDA 1990 and 21 CFR 807.92.
Syneron Medical Ltd., Sultam Industrial park, P.O.R.550, Submitter: Yokneam Elite 20692, Israel. Tel. +972-4-909-6200 ext. 352, Fax +972-4-909-6202
Name of the Device: Vela smooth, Shaper
- Predicate Devices: Vela smooth, Shaper is substantially equivalent to a combination of the following devices: LPG therapeutic massager, manufactured by LPG systems and subject of K990445. WS-501 Heat lamp, manufactured by Lhasa Medical Inc. and subject of K013197. TDP CQ-27 heat lamp, manufactured by Lhasa Medical, Inc. and subject of K003538. Aurora DS, manufactured by Syneron medical Ltd. and subject of K031988. ThermaCool TC, manufactured by Thermage Inc. and subject of K030142.
- Device Description: The Vela smooth, Shaper treatment is based on the simultaneous application of heat to the tissue with light energy at a controlled Infrared wavelength, conducted RF energy, and mechanical manipulations of the skin.
The Vela smooth, Shaper is indicated for the relief of minor muscle aches and pain. Relieve of muscle spasm. Temporary improvement of local blood circulation. Temporary reduction in the appearance of cellulite.
Based upon an analysis of the overall performance characteristic for the device, Syneron Medical Ltd. believes that no significant differences exit. Therefore the Vela smooth, Shaper should raise no new issues of safety or effectiveness.
February 13, 2005
Date
Jur Wahler
Dr. Amir Waldman, Director regulatory affairs Syneron medical Ltd.
{1}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is a circular seal with the words "U.S. Department of Health & Human Services - USA" arranged around the perimeter. Inside the circle is an abstract image of an eagle or other bird with three stylized lines representing its wings or body.
JUN 9 - 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Syneron Medical, LTD. C/o Mr. Donald E. Segal Alston & Bird, LLP 601 Pennsylvania Avenue, N.W. North Building, 10th floor Washington, District of Columbia 20004
Re: K050397
Trade/Device Name: Vela smooth, Shaper Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: NUV Dated: May 23,2005 Received: May 23,2005
Dear Mr. Segal:
We have reviewed vour Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for iinnual registration. listing of devices, good manufacturing practice. labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulationsadministered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{2}------------------------------------------------
Page 2 - Mr. Donald E. Segal
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation(21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115 . Also, please note the regulation entitled, ''Misbranding by reference to premarket notification'' (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.
Sincerety yours,
Miriam C. Provost, P
Miriam C. Provost, Ph.D. Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
| 510(k) Number (if known); | K050397 |
|---|---|
| Device Name: | Vela smooth, Shaper. |
| Indications For Use: | The Vela smooth, Shaper is indicated for the reliefof minor muscle aches and pain. Relief of muscle spamTemporary improvement of local blood circulation.Temporary reduction in the appearance of cellulite. |
区 Prescription Use _ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
ball
Sivision Sign-Off) Division of Consint, Fertorative and Neurological Devices
1 20 K ) Mozriber __ K OSO 397
Page 1 of _ 1
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.